Atezolizumab in Large Cell Neuroendocrine Carcinoma
Clinical trial NCT06049966 · COMPLETED
Trial details
- NCT number
- NCT06049966
- Sponsor
- Oncology Center of Biochemical Education And Research
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2025-09-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.